HomeALGS • NASDAQ
add
Aligos Therapeutics Inc
Previous close
$11.33
Day range
$11.20 - $11.63
Year range
$3.76 - $46.80
Market cap
70.83M USD
Avg Volume
80.08K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 741.00K | -41.61% |
Operating expense | 5.16M | 11.65% |
Net income | -31.54M | -63.75% |
Net profit margin | -4.26K | -180.43% |
Earnings per share | -3.04 | 0.98% |
EBITDA | -28.14M | -41.53% |
Effective tax rate | -0.18% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 99.10M | 32.27% |
Total assets | 109.76M | 24.13% |
Total liabilities | 37.93M | -1.04% |
Total equity | 71.83M | — |
Shares outstanding | 6.15M | — |
Price to book | 0.97 | — |
Return on assets | -58.00% | — |
Return on capital | -75.98% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -31.54M | -63.75% |
Cash from operations | -24.34M | -21.11% |
Cash from investing | 47.68M | 358.58% |
Cash from financing | -53.00K | -1,225.00% |
Net change in cash | 23.28M | 339.88% |
Free cash flow | -13.87M | -8.08% |
About
Founded
2018
Headquarters
Website
Employees
70
